Amylin and GLP-1 combination or co-agonist
Cagsema sc
CAGSEMA_SC
- Mechanism
- Amylin analogue co-formulated with a GLP-1 receptor agonist (cagrilintide with semaglutide) or unimolecular amylin and GLP-1 agonist (amycretin)
- Trials
- 0
- Participants in these arms
- 0
Doses in this pooled treatment